HIV, hepatitis B, and hepatitis C in Zambia

HIV, hepatitis B, and hepatitis C in Zambia

Blog Article

Objectives : Epidemiologic data of HIV and viral hepatitis coinfection are needed in sub-Saharan Africa to guide health policy for hepatitis screening and optimized antiretroviral therapy (ART).Materials and Methods: We screened 323 sofia barclay sexy HIV-infected, ART-eligible adults for hepatitis B surface antigen (HBsAg) and hepatitis C antibody (HCV Ab) at a tertiary hospital in Lusaka, Zambia.We collected basic demographic, medical, and laboratory data to determine predictors for coinfection.Results: Of 323 enrolled patients, 32 (9.

9%; 95% CI=6.7-13.2%) were HBsAg positive, while 4 (1.2%; 95% CI=0.

03-2.4%) were HCV Ab positive.Patients with hepatitis B coinfection flexcon reverse osmosis water storage tank were more likely to be 200 IU/L) was uncommon and did not differ between the two groups (3.4% vs.

2.3%; P=0.5).We were unable to determine predictors of hepatitis C infection due to the low prevalence of disease.

Conclusions: HIV and hepatitis B coinfection was common among patients initiating ART at this tertiary care facility.Routine screening for hepatitis B should be considered for HIV-infected persons in southern Africa.